Outsourcing Clinical Trials West Coast, Burlingame CA, 12 – 13 February 2019


Meet Dr Simon Hutchings, Director of Scientific Affairs at Outsourcing Clinical Trials West Coast, February 12 & 13 2019. Find out how we can add value and reduce risk with your protocol development Discover why our purpose-built clinical pharmacology unit attracts US drug developers Discover how adaptive clinical trial design can accelerate early clinical development

How Simbec-Orion Are Supporting COPD Research & Development


Not only is today is World COPD Day, but November is also COPD awareness month. Also known as chronic obstructive pulmonary disease, COPD is a group of lung conditions which have no cure and are characterised by a narrowing of the airways. According to the British Lung Foundation, COPD affects 2% of the UK population, [...]

View On Demand Webinar – ESMO Update: State of the Art in Early Phase Oncology Trial Design


If you missed our live ESMO Update: State of the Art in Early Phase Oncology Trial Design webinar you can view on demand now. The science looks promising and you have secured vital funding to take your compound to the clinical stage. What is the best strategy for operationalizing your oncology study in a clinical setting to meet your [...]

SCRIP Awards Finalists, 2018


We are delighted to have been selected as finalists for ‘Best Contract Research Organisation of the Year – Specialist Providers’ at the 14th Annual Scrip Awards. Our entry was selected based on demonstrating how our capabilities and strong operational delivery directly benefits small/mid -size drug developers meet their clinical and commercial objectives, specifically in oncology, [...]

Simbec-Orion Hosts Successful Symposia at British Embassy in Copenhagen


Attendees from selected biotechnology companies from across the Nordic region were welcomed by the Simbec-Orion team at our symposium hosted at the British Embassy in Copenhagen on 16 May, supported by the UK’s Department of International Trade (DIT). The ‘Clinical Development Plans for Rare Disease and Oncology Therapies to Improve your Net Present Value’ symposium [...]

Orphan Drug Designation (ODD): Meeting The Unmet Need


If you missed our live Orphan Drug Designation (ODD) webinar you can view on demand now. Achieving ODD status, is a significant step enabling your product to be licensed faster, cost-efficiently, and achieve market exclusivity for 10 years. Join this 1-hour webinar where the audience will gain a practical overview in the steps to achieve [...]

Come Talk To Us at World Orphan Drug Congress, USA, 25 – 27 April


Meet the team Douglas Cookson, SVP Commercial Development, Simbec-Orion Group Dani Hristova, Associate Medical Director, Orion Clinical Jeff Trickett, Director Business Development, Simbec-Orion Group Steve Novak, Director Business Development, Simbec-Orion Group